Benign Prostate Hyperplasia
1 competing product in clinical development for Benign Prostate Hyperplasia.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| 5 mg Tadalafil + Placebo + 0.2 mg Tamsulosin | Eli Lilly | Phase 3 | Completed | 77 |